Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5219908
Max Phase: Preclinical
Molecular Formula: C24H27ClFN3O
Molecular Weight: 427.95
Associated Items:
ID: ALA5219908
Max Phase: Preclinical
Molecular Formula: C24H27ClFN3O
Molecular Weight: 427.95
Associated Items:
Canonical SMILES: O=C(c1cccc(Cl)c1)N1CCC(CNCCCc2c[nH]c3ccc(F)cc23)CC1
Standard InChI: InChI=1S/C24H27ClFN3O/c25-20-5-1-3-18(13-20)24(30)29-11-8-17(9-12-29)15-27-10-2-4-19-16-28-23-7-6-21(26)14-22(19)23/h1,3,5-7,13-14,16-17,27-28H,2,4,8-12,15H2
Standard InChI Key: HCVIGPQXPNXQSD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 427.95 | Molecular Weight (Monoisotopic): 427.1827 | AlogP: 5.04 | #Rotatable Bonds: 7 |
Polar Surface Area: 48.13 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.31 | CX LogP: 4.68 | CX LogD: 1.93 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.52 | Np Likeness Score: -1.32 |
1. Yuan RX, Jiang KY, Wu JW, Zhang ZX, Li MS, Li JQ, Ni F.. (2022) Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT1A., 76 [PMID:36202190] [10.1016/j.bmcl.2022.129006] |
Source(1):